AAV Downstream Process Development Intern - Cambridge, MA jobs in United States
cer-icon
Apply on Employer Site
company-logo

AstraZeneca · 1 day ago

AAV Downstream Process Development Intern - Cambridge, MA

AstraZeneca is seeking undergraduate senior and Master's level students for a 10-week internship role. The position involves executing chromatography and filtration unit operations, supporting experimental workflows, and analyzing results from experiments.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Independently execute chromatography and filtration unit operations
Work with matrix teams to support experimental workflows
Curate and analyze results from executed experiments, present findings to immediate team and broader group

Qualification

ChromatographyFiltrationWet lab skillsData analysisData visualizationUnderstanding AI trendsFirst principles modelingTeam collaborationPresentation skills

Required

Undergraduate senior and Master's level students majoring in Chemical Engineering, Biomedical Engineering, or a related discipline
Candidates must have an expected graduation date after August 2026
Wet lab skills such as pipetting, sample handling and preparation (of biological samples) are required
Comfortability working in matrix team environments, presenting findings to mentors and group members in meetings is required
Ability to report onsite to Cambridge, MA 5 days per week. This role will not provide relocation assistance
US Work Authorization is required at time of application
This role will not be providing CPT support

Preferred

Experience with data analysis (using Excel, R etc.) and data visualization (Excel, Prism etc.) is preferred
Understanding of relevant/applicable trends in AI for data analysis and understanding of first principles modeling is preferred

Company

AstraZeneca

company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.

Funding

Current Stage
Public Company
Total Funding
$5.26B
2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Chief Executive Officer
leader-logo
Aradhana Sarin
Group CFO and Executive Director
linkedin
Company data provided by crunchbase